article thumbnail

Amy Turnquist

Pharma Marketing Network

Amy Turnquist has more than 20 years of experience leading teams to create and deliver innovative, client-centric solutions that connect pharmaceutical brands with their HCP and consumer audiences. An avid connector and networker, Amy can be reached at linkedin.com/in/amyturnquist or amy.turnquist@northhighland.com.

Media 98
article thumbnail

Weekly Roundup – October 02, 2019

CloserIQ

How To Generate More Sales Lead. Much has changed in lead generation in recent years, but one thing remains the same: Generating leads is critical for success as a sales professional. The more leads you’re able to develop, the better chance you have of meeting or exceeding quota. “Networking.

Sales 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Weekly Roundup – October 02, 2019

CloserIQ

How To Generate More Sales Lead. Much has changed in lead generation in recent years, but one thing remains the same: Generating leads is critical for success as a sales professional. The more leads you’re able to develop, the better chance you have of meeting or exceeding quota. “Networking.

Sales 40
article thumbnail

Weekly Roundup – Feb 15, 2019

CloserIQ

If you want to build your career and not just find a job, developing your professional network will be far more valuable than uploading your resume to every listing site on the internet.”. If you’re looking for a career shift, there are certification programs that lead to high-paying jobs.”. Selling Strategies. Entrepreneur).

article thumbnail

HCP’s use of social media: the good and the not so good

World of DTC Marketing

HCPs are also connecting more than ever: one study showed that HCP posts about healthcare increased from 10% in 2013 to 50% in 2019. With over a million members, Doximity is the largest professional medical network in the United States , including three-quarters of all U.S. 33 Even now, nearly 70% of all HCPs are digital natives.

Media 294
article thumbnail

Gilead to acquire MiroBio for $405 million

European Pharmaceutical Review

UK-based MiroBio’s lead investigational antibody, MB272 – a selective agonist of immune inhibitory receptor B- and T-Lymphocyte Attenuator (BTLA) – recently entered Phase I clinical trials. “We MiroBio was spun out of Oxford University in 2019.

article thumbnail

Cancer Research UK partnership aims to back 10 new startups

pharmaphorum

London-based DSV has been working since 2019 with the charity’s Cancer Research Horizons unit, an incubator organisation which was set up to nurture new discoveries in academia and help to bring them to patients.